MXPA05008109A - Derivados de urea y tiourea. - Google Patents
Derivados de urea y tiourea.Info
- Publication number
- MXPA05008109A MXPA05008109A MXPA05008109A MXPA05008109A MXPA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A MX PA05008109 A MXPA05008109 A MX PA05008109A
- Authority
- MX
- Mexico
- Prior art keywords
- urea
- thiourea derivatives
- moet
- zene
- exc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Quinoline Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invencion se dirige a una nueva clase de compuestos quinolin-zeno y z-exc cromeno que han sido derivatizados en la posicion 6 con una urea o este resto de urea, y su uso como agentes antagonistas de los androgenos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44640903P | 2003-02-11 | 2003-02-11 | |
PCT/IB2004/000295 WO2004072044A2 (en) | 2003-02-11 | 2004-01-30 | Urea and thiourea derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05008109A true MXPA05008109A (es) | 2005-09-21 |
Family
ID=32869502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05008109A MXPA05008109A (es) | 2003-02-11 | 2004-01-30 | Derivados de urea y tiourea. |
Country Status (7)
Country | Link |
---|---|
US (1) | US7074933B2 (es) |
EP (1) | EP1603882A2 (es) |
JP (1) | JP2006517578A (es) |
BR (1) | BRPI0407354A (es) |
CA (1) | CA2515589A1 (es) |
MX (1) | MXPA05008109A (es) |
WO (1) | WO2004072044A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008540327A (ja) * | 2004-09-02 | 2008-11-20 | シー.ワイ. シー,チャールズ | 核内受容体転写因子の分解を増強するための方法及び組成物並びにその使用 |
GB0720061D0 (en) * | 2007-10-13 | 2007-11-21 | Finnen Michael | Method & composition for the treatment of acne and sebum dependent pilosebaceous disorders |
CN108148034B (zh) * | 2018-01-12 | 2021-06-01 | 青岛农业大学 | 一类含氟取代脲基香豆素衍生物及其除草与杀菌用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5811947B2 (ja) * | 1976-12-10 | 1983-03-05 | 大塚製薬株式会社 | カルボスチリル誘導体 |
JPS58102936A (ja) * | 1981-12-15 | 1983-06-18 | Konishiroku Photo Ind Co Ltd | ハロゲン化銀カラ−写真感光材料 |
JPS59164554A (ja) * | 1983-03-08 | 1984-09-17 | Fuji Photo Film Co Ltd | ハロゲン化銀カラ−写真感光材料 |
US6017924A (en) * | 1996-06-27 | 2000-01-25 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
EP1212322A2 (en) | 1999-08-27 | 2002-06-12 | Ligand Pharmaceuticals Incorporated | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
JP2003508402A (ja) | 1999-08-27 | 2003-03-04 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲン受容体モジュレーター化合物および方法 |
-
2004
- 2004-01-30 EP EP04706751A patent/EP1603882A2/en not_active Withdrawn
- 2004-01-30 CA CA002515589A patent/CA2515589A1/en not_active Abandoned
- 2004-01-30 WO PCT/IB2004/000295 patent/WO2004072044A2/en active Application Filing
- 2004-01-30 MX MXPA05008109A patent/MXPA05008109A/es not_active Application Discontinuation
- 2004-01-30 BR BR0407354-1A patent/BRPI0407354A/pt not_active IP Right Cessation
- 2004-01-30 JP JP2006502401A patent/JP2006517578A/ja not_active Withdrawn
- 2004-02-10 US US10/775,464 patent/US7074933B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7074933B2 (en) | 2006-07-11 |
CA2515589A1 (en) | 2004-08-26 |
JP2006517578A (ja) | 2006-07-27 |
WO2004072044A2 (en) | 2004-08-26 |
BRPI0407354A (pt) | 2006-01-10 |
US20040266820A1 (en) | 2004-12-30 |
WO2004072044A3 (en) | 2004-11-11 |
EP1603882A2 (en) | 2005-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176571A0 (en) | Substituted azole derivatives, compositions, and methods of use | |
EP1626717A4 (en) | BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS | |
MXPA04008772A (es) | Composiciones de clorhidrato de naltrexona. | |
HK1115752A1 (en) | Benzazole derivatives, compositions, and methods of use as | |
ECSP12007067A (es) | Derivados de quinazolinona útiles como antagonistas vanilloides | |
HN2003000285A (es) | Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa | |
TW200716525A (en) | Process for preparation of sulfamide derivatives | |
MXPA03006363A (es) | Derivados de urea como antagonistas de integrinas alfa-4. | |
IL174215A0 (en) | Benzimidazole derivatives, compositions containing them preparation thereof and uses thereof | |
UA92730C2 (ru) | Аналоги бензазола и их применение | |
IL172023A0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
IL172027A0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
UY28917A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico | |
DE60321722D1 (de) | Derivate von aryl-chinazolin/aryl-2amino-phenyl-methanon zurförderung der freisetzung von parathormon | |
PL371127A1 (en) | 6-aminomorphinane derivatives, method for the production and use thereof | |
MXPA03010158A (es) | Sulfonamidas. | |
MXPA05007605A (es) | Antagonista del receptor de androgenos. | |
PL1898901T3 (pl) | Stabilne postacie dawkowania spiro i dispiro 1, 2, 4-trioksolanowych związków przeciwmalarycznych | |
DE602005010453D1 (de) | Antibakterielle zusammensetzung | |
MXPA05009988A (es) | Derivados de 6-sulfonamida quinolina y cromeno como antagonistas de los receptores de androgenos. | |
PT1638943E (pt) | Novos derivados de imidazoles, sua preparação e sua utilização como medicamento | |
MXPA05008109A (es) | Derivados de urea y tiourea. | |
SI1532141T1 (sl) | 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi | |
BR0208221A (pt) | Combinação de uma taxano e uma cinase dependente de ciclina | |
IL165942A0 (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of vib or both vib and via receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |